---
input_text: Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement
  disorders. Modulation of subthalamic nucleus (STN) firing patterns with injections
  of depolarizing currents into the STN is an important advance for the treatment
  of hypokinetic movement disorders, especially Parkinson's disease (PD). Chorea,
  ballism and dystonia are prototypical examples of hyperkinetic movement disorders.
  In our previous study, normal rats without nigro-striatal lesion were rendered hypokinetic
  with hyperpolarizing currents injected into the STN. Therefore, modulation of the
  firing pattern by injection of a hyperpolarizing current into the STN could be an
  effective treatment for hyperkinetic movement disorders. We investigated the effect
  of injecting a hyperpolarizing current into the STNs of two different types of hyperkinetic
  animal models and a patient with an otherwise uncontrollable hyperkinetic disorder.
  The two animal models included levodopa-induced hyperkinetic movement in parkinsonian
  rats (L-DOPA-induced dyskinesia model) and hyperkinesia induced by an intrastriatal
  injection of 3-nitropropionic acid (Huntington disease model), covering neurodegeneration-related
  as well as neurotoxin-induced derangement in the cortico-subcortical re-entrant
  loops. Delivering hyperpolarizing currents into the STN readily alleviated the hyperkinetic
  behaviors in the two animal models and in the clinical case, with an evident increase
  in subthalamic burst discharges in electrophysiological recordings. Application
  of a hyperpolarizing current into the STN via a Deep brain stimulation (DBS) electrode
  could be an effective general therapy for a wide spectrum of hyperkinetic movement
  disorders.
raw_completion_output: |-
  primary_disease: Hyperkinetic movement disorders

  medical_actions: Injection of depolarizing currents into the STN; Injection of hyperpolarizing currents into the STN; Deep brain stimulation (DBS)

  symptoms: Hyperkinetic behaviors

  chemicals: Levodopa; 3-nitropropionic acid

  action_annotation_relationships: Injection of hyperpolarizing currents into the STN TREATS Hyperkinetic behaviors IN Hyperkinetic movement disorders; Deep brain stimulation (DBS) TREATS Hyperkinetic behaviors IN Hyperkinetic movement disorders; Injection of depolarizing currents into the STN TREATS Hyperkinetic movement disorders IN Parkinson's disease (with Levodopa)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Injection of depolarizing currents into the STN TREATS Hyperkinetic movement disorders IN Parkinson's disease (with Levodopa)

  ===

extracted_object:
  primary_disease: Hyperkinetic movement disorders
  medical_actions:
    - Injection of depolarizing currents into the STN
    - Injection of hyperpolarizing currents into the STN
    - MAXO:0000943
  symptoms:
    - Hyperkinetic behaviors
  chemicals:
    - CHEBI:15765
    - CHEBI:16348
  action_annotation_relationships:
    - subject: Injection of hyperpolarizing currents into the STN
      predicate: TREATS
      object: Hyperkinetic behaviors
      qualifier: Hyperkinetic movement disorders
    - subject: <Deep brain stimulation>
      predicate: <TREATS>
      object: <Hyperkinetic behaviors>
      qualifier: <Hyperkinetic movement disorders>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: Injection into the STN
      predicate: TREATS
      object: Hyperkinetic movement disorders
      qualifier: MONDO:0005180
      object_qualifier: with Levodopa
      subject_extension: depolarizing currents
      object_extension: Levodopa
named_entities:
  - id: MONDO:0007739
    label: Huntington Disease
  - id: CHEBI:16908
    label: NADH
  - id: HP:0002180
    label: neurodegeneration
  - id: MAXO:0001001
    label: gene therapies
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0020696
    label: Vitamin B12 Deficiency
  - id: MAXO:0000760
    label: Vitamin B12 supplementation
  - id: MAXO:0000427
    label: MRI of the brain
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0020380
    label: Spinocerebellar Ataxia (SCA)
  - id: HP:0001272
    label: Cerebellar atrophy
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MONDO:0017276
    label: frontotemporal dementia
  - id: MONDO:0004976
    label: amyotrophic lateral sclerosis
  - id: MONDO:0007661
    label: Tourette Syndrome
  - id: HP:0002072
    label: Chorea
  - id: MONDO:0005071
    label: Neurological Disorders
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0012174
    label: glioblastoma
  - id: MONDO:0005109
    label: HIV
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: CHEBI:16243
    label: quercetin
  - id: CHEBI:3962
    label: curcumin
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:75095
    label: chrysin
  - id: CHEBI:28821
    label: piperine
  - id: CHEBI:17620
    label: ferulic acid
  - id: CHEBI:78330
    label: huperzine A
  - id: CHEBI:16118
    label: berberine
  - id: CHEBI:2979
    label: baicalein
  - id: CHEBI:28230
    label: hesperetin
  - id: CHEBI:26536
    label: retinoic acid
  - id: HP:0002015
    label: Dysphagia
  - id: CHEBI:50202
    label: Naringenin
  - id: CHEBI:16348
    label: 3-nitropropionic acid
  - id: CHEBI:28790
    label: Serotonin
  - id: HP:0000709
    label: psychosis
  - id: HP:0011951
    label: aspiration pneumonia
  - id: HP:0000716
    label: depression
  - id: MAXO:0000065
    label: aerobic exercises
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assays
  - id: CHEBI:53444
    label: potassium dichromate
  - id: CHEBI:141442
    label: Manganese (Mn)
  - id: HP:0100021
    label: Cerebral palsy
  - id: HP:0001915
    label: Aplastic anemia
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0000708
    label: behavioral problems
  - id: HP:0004421
    label: Elevated systolic blood pressure
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005301
    label: multiple sclerosis
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:7872
    label: oxytocin
  - id: CHEBI:9937
    label: vasopressin
  - id: HP:0033429
    label: neuroinflammation
  - id: MAXO:0000016
    label: Cell Therapy
  - id: CHEBI:6437
    label: levetiracetam
  - id: MAXO:0000900
    label: Electrocardiograms (ECGs) collection
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: MONDO:0010096
    label: tardive dyskinesia
  - id: HP:0005268
    label: Spontaneous abortion
  - id: CHEBI:16675
    label: quinolinic acid
  - id: MONDO:0001627
    label: Dementias
  - id: HP:0001300
    label: parkinsonism
  - id: CHEBI:76720
    label: antisense oligonucleotide
  - id: CHEBI:192545
    label: LY379268
  - id: HP:0005305
    label: cerebral venous thrombosis
  - id: HP:0001891
    label: iron-deficiency anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0000657
    label: Ocular Motor Apraxia
  - id: HP:0025464
    label: Oxidative stress
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0002511
    label: Alzheimer's disease
  - id: HP:0001297
    label: Stroke
  - id: MAXO:0009004
    label: Exome sequencing
  - id: HP:0001251
    label: Ataxia
  - id: HP:0000726
    label: Dementia
  - id: HP:0001332
    label: Dystonia
  - id: HP:0002313
    label: Spastic paraparesis
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000137
    label: PET scan
  - id: HP:0000750
    label: Speech Difficulties
  - id: HP:0002446
    label: Astrogliosis
  - id: CHEBI:76931
    label: N-acetylaspartylglutamate
  - id: MONDO:0005395
    label: Movement disorders
  - id: HP:0100033
    label: Tic disorders
  - id: CHEBI:50114
    label: Oestrogens
  - id: CHEBI:50113
    label: Androgens
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0000943
    label: Deep brain stimulation (DBS)
  - id: CHEBI:15765
    label: Levodopa
